Mitochondrial replacement therapy marketed as fertility fix for older women, evidence lacking

A pioneering IVF technique aimed at preventing mitochondrial disease is being marketed to older women as a fertility treatment, despite insufficient evidence of efficacy. Scientists warn that patients are being misled, and the practice raises regulatory and ethical concerns. The development highlights a gap between experimental reproductive technology and its commercial application.

AI disclosure: Model-written summary of the source, not a verified fact. Check the sources. How Mosaic works